Free Trial

Jackson Creek Investment Advisors LLC Invests $276,000 in Ingredion Incorporated (NYSE:INGR)

Ingredion logo with Consumer Staples background
Remove Ads

Jackson Creek Investment Advisors LLC purchased a new position in shares of Ingredion Incorporated (NYSE:INGR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 2,005 shares of the company's stock, valued at approximately $276,000.

Several other institutional investors have also modified their holdings of INGR. Assetmark Inc. raised its holdings in shares of Ingredion by 38,341.7% in the fourth quarter. Assetmark Inc. now owns 509,352 shares of the company's stock valued at $70,067,000 after purchasing an additional 508,027 shares during the last quarter. Hennessy Advisors Inc. acquired a new position in shares of Ingredion during the 4th quarter worth about $58,642,000. Pacer Advisors Inc. grew its holdings in shares of Ingredion by 16.5% in the 4th quarter. Pacer Advisors Inc. now owns 1,890,488 shares of the company's stock valued at $260,056,000 after acquiring an additional 268,389 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Ingredion during the fourth quarter worth about $31,752,000. Finally, Caisse DE Depot ET Placement DU Quebec bought a new position in Ingredion in the third quarter valued at approximately $17,094,000. Institutional investors own 85.27% of the company's stock.

Ingredion Stock Performance

NYSE:INGR traded down $2.63 during mid-day trading on Wednesday, reaching $130.39. 896,055 shares of the company's stock were exchanged, compared to its average volume of 600,644. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.69 and a current ratio of 2.62. The firm has a market capitalization of $8.37 billion, a PE ratio of 13.43, a price-to-earnings-growth ratio of 1.03 and a beta of 0.75. Ingredion Incorporated has a one year low of $109.51 and a one year high of $155.44. The business's fifty day simple moving average is $131.97 and its two-hundred day simple moving average is $136.64.

Remove Ads

Ingredion (NYSE:INGR - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $2.63 earnings per share for the quarter, beating analysts' consensus estimates of $2.54 by $0.09. The company had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.82 billion. Ingredion had a net margin of 8.71% and a return on equity of 18.62%. The firm's quarterly revenue was down 6.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.65 earnings per share. Analysts anticipate that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.

Ingredion Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, January 21st. Investors of record on Thursday, January 2nd were given a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date was Thursday, January 2nd. Ingredion's payout ratio is currently 32.96%.

Insider Activity at Ingredion

In other Ingredion news, CEO James P. Zallie sold 10,815 shares of the business's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $125.88, for a total transaction of $1,361,392.20. Following the completion of the transaction, the chief executive officer now directly owns 34,127 shares in the company, valued at $4,295,906.76. The trade was a 24.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Stephens cut their price objective on Ingredion from $155.00 to $150.00 and set an "equal weight" rating for the company in a report on Wednesday, February 5th. StockNews.com cut shares of Ingredion from a "strong-buy" rating to a "buy" rating in a report on Thursday, February 6th. UBS Group lifted their price target on Ingredion from $165.00 to $173.00 and gave the stock a "buy" rating in a report on Friday, November 15th. Oppenheimer cut their price objective on Ingredion from $178.00 to $167.00 and set an "outperform" rating for the company in a research report on Wednesday, February 5th. Finally, BMO Capital Markets dropped their price target on Ingredion from $147.00 to $133.00 and set a "market perform" rating on the stock in a research note on Wednesday, February 5th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $158.20.

Check Out Our Latest Stock Analysis on Ingredion

Ingredion Company Profile

(Free Report)

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.

Featured Articles

Institutional Ownership by Quarter for Ingredion (NYSE:INGR)

Should You Invest $1,000 in Ingredion Right Now?

Before you consider Ingredion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.

While Ingredion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

The Future of Healthcare: 3 AI Stocks Leading the Way

The Future of Healthcare: 3 AI Stocks Leading the Way

2025 promises explosive growth for AI, but which companies are making a difference in healthcare? Chris Markoch highlights three stocks leading the charge.

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads